CYTX Share Price

Open 0.45 Change Price %
High 0.45 1 Day -0.01 -2.44
Low 0.39 1 Week 0.00 0.00
Close 0.40 1 Month -0.06 -13.04
Volume 298008 1 Year -1.24 -75.61
52 Week High 2.13
52 Week Low 0.28
CYTX Important Levels
Resistance 2 0.46
Resistance 1 0.43
Pivot 0.41
Support 1 0.37
Support 2 0.34
NASDAQ USA Most Active Stocks
YHOO 52.58 0.00%
YHOO 52.58 0.00%
YHOO 52.58 0.00%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
MU 44.31 6.39%
MU 44.31 6.39%
MU 44.31 6.39%
RIMM 13.03 0.39%
More..
NASDAQ USA Top Gainers Stocks
LOCM 0.09 50.00%
SCHS 0.04 33.33%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
HLIT 3.70 25.42%
OTT 2.39 25.13%
QNST 8.90 20.76%
VRTA 4.00 19.40%
SNSS 2.56 19.07%
GCFB 0.44 18.92%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
GMETP 0.15 -76.92%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
More..

Cytori Therapeutics Inc (NASDAQ: CYTX)

CYTX Technical Analysis 5
As on 31st Oct 2017 CYTX Share Price closed @ 0.40 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.07 & Strong Sell for SHORT-TERM with Stoploss of 0.40 we also expect STOCK to react on Following IMPORTANT LEVELS.
CYTX Target for November
1st Target up-side 0.68
2nd Target up-side 0.88
3rd Target up-side 1.08
1st Target down-side 0.12
2nd Target down-side -0.08
3rd Target down-side -0.28
CYTX Other Details
Segment EQ
Market Capital 201966640.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.cytori.com
CYTX Address
CYTX
3020 Callan Road
San Diego, CA 92121
United States
Phone: 858-458-0900
Fax: 858-458-0994
CYTX Latest News
Interactive Technical Analysis Chart Cytori Therapeutics Inc ( CYTX NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Cytori Therapeutics Inc
CYTX Business Profile
Cytori Therapeutics, Inc. develops cell therapies based on autologous adipose-derived stem and regenerative cells (ADRCs) to treat cardiovascular disease and repair soft tissue defects. The advanced therapeutic application in the Company's clinical pipeline is for cardiovascular disease. The Company�s products include Celbrush, Puregraft, and Cytori LipoBank. The Celbrush is available in the 10 milliliter and 3 milliliter sizes and is used in conjunction with a Soft-Ject Syringe in the corresponding size. The Puregraft System is developed for autologous fat grafting and aesthetic body contouring. The Puregraft System is available in two sizes: 250 milliliter, which processes 50-250 milliliter of tissue, and 850 milliliter, which processes 200-850 milliliter of tissue. The Cytori LipoBank is a GTP-compliant cryopreservation system that offers a long-term storage option for viable adipose tissue after a single liposuction.